Correlation between PD-L1 Expression of Non-Small Cell Lung Cancer and Data from IVIM-DWI Acquired during Magnetic Resonance of the Thorax: Preliminary Results.

intravoxel incoherent motion (IVIM) non-small cell lung cancer (NSCLC) programmed death-ligand 1 (PD-L1)

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
16 Nov 2022
Historique:
received: 14 10 2022
revised: 12 11 2022
accepted: 14 11 2022
entrez: 26 11 2022
pubmed: 27 11 2022
medline: 27 11 2022
Statut: epublish

Résumé

This study aims to investigate the correlation between intravoxel incoherent motion diffusion-weighted imaging (IVIM-DWI) parameters in magnetic resonance imaging (MRI) and programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer (NSCLC). Twenty-one patients diagnosed with stage III NSCLC from April 2021 to April 2022 were included. The tumors were distinguished into two groups: no PD-L1 expression (<1%), and positive PD-L1 expression (≥1%). Conventional MRI and IVIM-DWI sequences were acquired with a 1.5-T system. Both fixed-size ROIs and freehand segmentations of the tumors were evaluated, and the data were analyzed through a software using four different algorithms. The diffusion (D), pseudodiffusion (D*), and perfusion fraction (pf) were obtained. The correlation between IVIM parameters and PD-L1 expression was studied with Pearson correlation coefficient. The Wilcoxon−Mann−Whitney test was used to study IVIM parameter distributions in the two groups. Twelve patients (57%) had PD-L1 ≥1%, and 9 (43%) <1%. There was a statistically significant correlation between D* values and PD-L1 expression in images analyzed with algorithm 0, for fixed-size ROIs (189.2 ± 65.709 µm²/s × 104 in no PD-L1 expression vs. 122.0 ± 31.306 µm²/s × 104 in positive PD-L1 expression, p = 0.008). The values obtained with algorithms 1, 2, and 3 were not significantly different between the groups. The IVIM-DWI MRI parameter D* can reflect PD-L1 expression in NSCLC.

Identifiants

pubmed: 36428726
pii: cancers14225634
doi: 10.3390/cancers14225634
pmc: PMC9688282
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Clin Imaging Sci. 2011;1:27
pubmed: 21966624
Cancer Cytopathol. 2017 Dec;125(12):896-907
pubmed: 29024471
J Clin Oncol. 2022 Apr 20;40(12):1301-1311
pubmed: 35108059
Cancers (Basel). 2020 Dec 11;12(12):
pubmed: 33322522
Eur J Radiol. 2015 Mar;84(3):509-515
pubmed: 25554007
Thorac Cancer. 2020 Feb;11(2):362-368
pubmed: 31808285
JCI Insight. 2016 Sep 8;1(14):e89014
pubmed: 27699239
Diagn Interv Radiol. 2021 Mar;27(2):214-218
pubmed: 33455898
J Clin Oncol. 2022 Oct 28;:JCO2102885
pubmed: 36306479
BMC Cancer. 2020 Aug 24;20(1):799
pubmed: 32831052
J Thorac Dis. 2018 Nov;10(Suppl 33):S4031-S4033
pubmed: 30631547
J Immunother Cancer. 2022 Jun;10(6):
pubmed: 35649657
N Engl J Med. 2017 Jun 22;376(25):2415-2426
pubmed: 28636851
J Clin Oncol. 2017 Dec 10;35(35):3924-3933
pubmed: 29023213
Cancer Imaging. 2021 Jan 13;21(1):11
pubmed: 33441183
Radiology. 1986 Nov;161(2):401-7
pubmed: 3763909
IEEE Trans Med Imaging. 2018 Jan;37(1):35-46
pubmed: 28463188
Acta Radiol. 2019 Feb;60(2):168-176
pubmed: 29792040
Cancers (Basel). 2020 Oct 15;12(10):
pubmed: 33076303
Radiol Oncol. 2021 Jan 20;55(2):150-157
pubmed: 33764703
Magn Reson Med Sci. 2021 Jun 1;20(2):125-138
pubmed: 32536681
Magn Reson Imaging. 2019 May;58:24-31
pubmed: 30630071
J Thorac Imaging. 2013 May;28(3):138-50
pubmed: 23549390
Cancer Imaging. 2020 Jan 22;20(1):9
pubmed: 31969196
J Thorac Dis. 2019 Dec;11(12):4982-4991
pubmed: 32030214
Invest Radiol. 2016 Feb;51(2):90-9
pubmed: 26405835
Eur Radiol. 2021 Mar;31(3):1347-1358
pubmed: 32876833
JAMA Oncol. 2019 Dec 1;5(12):1749-1768
pubmed: 31560378
Front Oncol. 2021 Aug 23;11:703143
pubmed: 34497760
Eur Radiol. 2016 Aug;26(8):2547-58
pubmed: 26615557
Front Oncol. 2022 Mar 11;12:809430
pubmed: 35359367
J Thorac Oncol. 2022 Sep;17(9):e80-e83
pubmed: 36031295

Auteurs

Chandra Bortolotto (C)

Diagnostic Imaging and Radiotherapy Unit, Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, 27100 Pavia, Italy.
Radiology Institute, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.

Giulia Maria Stella (GM)

Unit of Respiratory Diseases, Department of Medical Sciences and Infective Diseases, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Department of Internal Medicine and Medical Therapeutics, University of Pavia, 27100 Pavia, Italy.

Gaia Messana (G)

Diagnostic Imaging and Radiotherapy Unit, Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, 27100 Pavia, Italy.

Antonio Lo Tito (A)

Diagnostic Imaging and Radiotherapy Unit, Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, 27100 Pavia, Italy.

Chiara Podrecca (C)

Department of Electrical, Computer and Biomedical Engineering, University of Pavia, 27100 Pavia, Italy.

Giovanna Nicora (G)

Department of Electrical, Computer and Biomedical Engineering, University of Pavia, 27100 Pavia, Italy.

Riccardo Bellazzi (R)

Department of Electrical, Computer and Biomedical Engineering, University of Pavia, 27100 Pavia, Italy.

Alessia Gerbasi (A)

Department of Electrical, Computer and Biomedical Engineering, University of Pavia, 27100 Pavia, Italy.

Francesco Agustoni (F)

Department of Medical Oncology, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.

Robert Grimm (R)

MR Application Predevelopment, Siemens Healthcare GmbH, 91052 Erlangen, Germany.

Domenico Zacà (D)

Siemens Healthcare, 20128 Milano, Italy.

Andrea Riccardo Filippi (AR)

Diagnostic Imaging and Radiotherapy Unit, Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, 27100 Pavia, Italy.
Department of Radiation Oncology, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.

Olivia Maria Bottinelli (OM)

Diagnostic Imaging and Radiotherapy Unit, Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, 27100 Pavia, Italy.

Lorenzo Preda (L)

Diagnostic Imaging and Radiotherapy Unit, Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, 27100 Pavia, Italy.
Radiology Institute, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.

Classifications MeSH